INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. & Encoura...
14 February 2019 - 7:16AM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces that it is investigating claims on behalf of
investors of Vanda Pharmaceuticals Inc. (“Vanda” or “the Company”)
(NASDAQ: VNDA) for violations of §§10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated
thereunder by the U.S. Securities and Exchange Commission.
The investigation focuses on whether the Company issued false
and/or misleading statements and/or failed to disclose information
pertinent to investors. Aurelius Value published a report on
February 11, 2019, which details a whistleblower lawsuit against
Vanda. The Lawsuit alleges that “Vanda has engaged in a series of
fraudulent schemes, some personally orchestrated by [its CEO], to
defraud government payors.” The whistleblower states that these
schemes involve “illegal off-label promotion of both of Vanda’s
drugs, Vanda’s participation in a fraud involving doctors writing
hundreds of ‘fake prescriptions’ and pocketing cash using
Vanda-issued copay cards, falsified documents in internal systems,
and resignations of senior executives who refused to participate in
illegal activity.” Based on this report, Vanda’s share price
dropped significantly the same day.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190213005758/en/
The Schall Law FirmBrian Schall, Esq.Sherin Mahdavian,
Esq.310-301-3335Cell:
424-303-1964info@schallfirm.comwww.schallfirm.com
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Apr 2024 to May 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From May 2023 to May 2024